Benefit-Risk Analysis of Upadacitinib compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis

Conaghan, P orcid.org/0000-0002-3478-5665, Cohen, S, Burmester, G et al. (11 more authors) (2022) Benefit-Risk Analysis of Upadacitinib compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis. Rheumatology and Therapy, 9 (1). pp. 191-206. ISSN 2198-6576

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

Ⓒ The Author(s) 2021. This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/bync/4.0/.

Keywords: Benefit–risk assessment; Number needed to treat; Number needed to harm; Efficacy; Safety; Rheumatoid arthritis; Upadacitinib; Janus kinase inhibitor
Dates:
  • Published: February 2022
  • Published (online): 23 November 2021
  • Accepted: 8 November 2021
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Musculoskeletal Medicine & Imaging (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Nov 2021 10:21
Last Modified: 04 Sep 2023 15:29
Status: Published
Publisher: Springer
Identification Number: 10.1007/s40744-021-00399-5
Open Archives Initiative ID (OAI ID):

Export

Statistics